NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

LTM Ltd Reports Decent Quarter with Revenue Growth

LTM Ltd (LTM) has reported a decent quarter with a revenue of USD 1.2 billion, marking a +1.2%/7% growth in constant currency (CC) terms on a quarterly (QoQ) and yearly (YoY) basis, respectively. This growth is supported by broad-based execution outside the banking, financial services, and insurance (BFSI) sector.

The company's earnings before interest and taxes (EBIT) margin moderated 100 basis points (bps) on a quarterly basis to 15.1%, impacted by phased wage hikes and productivity commitments in select accounts. However, this was partly cushioned by favourable currency movement. Adjusted profit after tax (PAT) came in at ₹13.4 billion, while reported PAT of ₹13.8 billion included a reversal of part one-off labour code related cost.

SegmentQoQ Growth (in %)
BFSI-4.9%
Other segments+1.2%/7%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Vertical performance remained mixed but encouraging beneath the headline margin softness. The BFSI segment declined 4.9% on a quarterly basis due to a deliberate productivity reset in a large client engagement. However, management indicated that the segment is nearing trough levels, with recovery expected from Q1 FY27 onward.

Outlook and Valuation

We remain cautious as the growth acceleration needed from current levels is steep and depends on successful AI monetization and M&A execution. While the strategy is promising, execution visibility is still limited. As a result, we have cut our valuation multiple from 30x to 23x FY28E EPS, arriving at a target price (TP) of ₹5,260. We maintain our BUY rating.

Investor Takeaway

Investors should remain cautious due to the steep growth acceleration needed from current levels.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.